You are here

Saxenda

EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk

BioSpace

Tue, 04/9/24 - 11:11 am

Many patients keep weight off after stopping anti-obesity meds: study

Axios

Wed, 01/24/24 - 10:44 am

European regulators probe suicide risk to Ozempic, other Novo drug Saxenda

BioPharma Dive

Mon, 07/10/23 - 09:40 pm

Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training

Financial Times

Mon, 02/13/23 - 10:44 am

A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity

Fierce Pharma

Mon, 08/29/22 - 10:40 am

Alzheimer's disease

Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis

Endpoints

Wed, 07/13/22 - 08:22 pm

Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchise

Fierce Pharma

Thu, 03/3/22 - 10:54 am

Insights into how Novo Nordisk's Saxenda cuts food cravings may inspire new obesity drugs

Fierce Biotech

Thu, 03/5/20 - 11:05 pm

NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions

Fierce Pharma

Sun, 01/26/20 - 01:40 pm

Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1

Fierce Pharma

Tue, 05/23/17 - 08:14 am

Novo Nordisk: Why The Diabetes Giant Will Continue To Grow

Seeking Alpha

Tue, 12/13/16 - 10:14 am

Novo Nordisk: Make-And-Take Strategy For The Obesity Drug Market

Seeking Alpha

Wed, 12/30/15 - 06:55 pm

Novo Nordisk: Has This Company Solved The Anti-Obesity Sector Woes?

Seeking Alpha

Tue, 09/29/15 - 08:58 am

Novo Nordisk Launches Obesity Medication In Canada - How Did That Happen?

Seeking Alpha

Mon, 09/14/15 - 10:55 am

Novo Nordisk executive fuels firm's new obesity fight

Medical Marketing and Media

Tue, 05/26/15 - 10:46 am

Jesper Høiland

What Novo Nordisk's Entry Into The Obesity Space Means To The Sector

Seeking Alpha

Fri, 04/24/15 - 11:03 am

Eyeing big niche in obesity, Novo rolls out Saxenda at $1,000 per month

Fierce Pharma

Wed, 04/22/15 - 01:55 pm

Novo Nordisk Quietly Becoming Big Player In Obesity Space

Seeking Alpha

Fri, 04/10/15 - 09:27 am

How Novo Nordisk plans to keep its eyes on the diabetes prize

BioPharma Dive

Wed, 03/18/15 - 11:38 am

Novo Nordisk Readies For Saxenda Launch - Investors Need To Keep Expectations Realistic

Seeking Alpha

Tue, 03/10/15 - 08:28 am

Pages